IMR Press / CEOG / Volume 25 / Issue 4 / pii/1998044

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research

Aggressive angiomyxoma of the vulva: expression of estroprogestinic receptors and follow-up

Show Less
1 Obstetrics and Gynecological Institute, University of Padua (Italy)
2 Pathological Department, University of Padua (Italy)
Clin. Exp. Obstet. Gynecol. 1998, 25(4), 141–143;
Published: 10 December 1998
Abstract

We hypothesized that the concomitant factor favoring neoplastic growth is a different genetic substrate specific in the female sex. Analysis of the data regarding the distribution of angiomyxomas in different age groups has strengthened this hypothesis suggesting that this tumor is correlated with complete maturity, in all probability hormonal. However it cannot be excluded that the tumor begins to develop at an early age, but since it has a slow growth rate, the phenomenon is delayed and is related to hormonal stimulation.

Keywords
Aggressive angiomyxoma
Vulva
Myxoid tumors
Estro-progestinic receptors.
Share
Back to top